Spots Global Cancer Trial Database for vitamin b12 1000 μg
Every month we try and update this database with for vitamin b12 1000 μg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189) | NCT02578680 | Non-Small-Cell ... | Pembrolizumab 2... Cisplatin Carboplatin Pemetrexed Folic acid 350-... Vitamin B12 100... Dexamethasone 4... Saline solution | 18 Years - | Merck Sharp & Dohme LLC | |
| Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients | NCT05751187 | Non-squamous NS... | Pembrolizumab Bevacizumab Pemetrexed Cisplatin Carboplatin Folic acid 350-... Vitamin B12 100... Dexamethasone 4... | 18 Years - 75 Years | Shanghai Chest Hospital | |
| Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients | NCT05751187 | Non-squamous NS... | Pembrolizumab Bevacizumab Pemetrexed Cisplatin Carboplatin Folic acid 350-... Vitamin B12 100... Dexamethasone 4... | 18 Years - 75 Years | Shanghai Chest Hospital | |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC | NCT04265534 | Non-Small Cell ... Non-squamous No... Non-Squamous No... KEAP1 Gene Muta... NRF2 Gene Mutat... NFE2L2 Gene Mut... | Telaglenastat Carboplatin Che... Pemetrexed Chem... Pembrolizumab I... Placebo Folic acid 400 ... Vitamin B12 100... Dexamethasone 4... | 18 Years - | Calithera Biosciences, Inc | |
| Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients | NCT05751187 | Non-squamous NS... | Pembrolizumab Bevacizumab Pemetrexed Cisplatin Carboplatin Folic acid 350-... Vitamin B12 100... Dexamethasone 4... | 18 Years - 75 Years | Shanghai Chest Hospital | |
| Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189) | NCT02578680 | Non-Small-Cell ... | Pembrolizumab 2... Cisplatin Carboplatin Pemetrexed Folic acid 350-... Vitamin B12 100... Dexamethasone 4... Saline solution | 18 Years - | Merck Sharp & Dohme LLC | |
| Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension Study | NCT03950674 | Non-Small-Cell ... | Pembrolizumab 2... Cisplatin Carboplatin Pemetrexed Folic acid 350-... Vitamin B12 100... Dexamethasone 4... Saline solution | 18 Years - | Merck Sharp & Dohme LLC | |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC | NCT04265534 | Non-Small Cell ... Non-squamous No... Non-Squamous No... KEAP1 Gene Muta... NRF2 Gene Mutat... NFE2L2 Gene Mut... | Telaglenastat Carboplatin Che... Pemetrexed Chem... Pembrolizumab I... Placebo Folic acid 400 ... Vitamin B12 100... Dexamethasone 4... | 18 Years - | Calithera Biosciences, Inc |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
